What are the dosing guidelines for intravenous calcium gluconate in adults and children for acute hypocalcaemia, calcium‑channel‑blocker toxicity, or hyperkalaemia?

Calcium Gluconate Dosing Guidelines

For acute symptomatic hypocalcemia in adults, administer 1–2 grams (10–20 mL of 10% solution) IV over 10 minutes with continuous ECG monitoring, followed by a continuous infusion of 0.5–2 mg/kg/hour (50–100 mL/hour of 10 grams diluted in 1 liter); for pediatric patients, give 50–100 mg/kg IV over 30–60 minutes, and for life-threatening hyperkalemia with ECG changes, give 15–30 mL of 10% calcium gluconate IV over 2–5 minutes. 1, 2, 3

Acute Symptomatic Hypocalcemia

Adult Dosing

• Initial bolus: 1–2 grams (10–20 mL of 10% calcium gluconate) IV over 10 minutes with continuous ECG monitoring 1, 3, 4
• Continuous infusion: Dilute 10 grams (100 mL of 10%) in 1 liter of normal saline or 5% dextrose and infuse at 50–100 mL/hour (0.5–2 mg/kg/hour) 1, 3, 4
• Maximum infusion rate: Do not exceed 200 mg/minute in adults 3
• Repeat bolus doses until symptoms resolve, then transition to continuous infusion 4

Pediatric Dosing

• Standard dose: 50–100 mg/kg IV infused slowly over 30–60 minutes with continuous ECG monitoring 1, 3
• Neonatal dose: 60 mg/kg IV over 30–60 minutes 1, 2
• Life-threatening arrhythmias: 100–200 mg/kg/dose via slow infusion with ECG monitoring for bradycardia 1, 2
• Maximum infusion rate: Do not exceed 100 mg/minute in pediatric patients, including neonates 3

Hyperkalemia with Cardiac Manifestations

Emergency Cardiac Stabilization

• Adult dose: 15–30 mL of 10% calcium gluconate (1.5–3 grams) IV over 2–5 minutes 5, 2
• Pediatric dose: 100–200 mg/kg/dose via slow infusion with ECG monitoring 1, 2
• Onset and duration: Effects begin within 1–3 minutes but last only 30–60 minutes; calcium does not lower potassium levels—it only protects against arrhythmias 2
• Repeat doses may be necessary as the effect is transient 5

Calcium Channel Blocker Toxicity

Adult Protocol

• Initial bolus: 30–60 mL (3–6 grams) of 10% calcium gluconate IV every 10–20 minutes until hemodynamic improvement 5, 1, 2
• Continuous infusion: 0.6–1.2 mL/kg/hour (0.06–0.12 g/kg/hour) of 10% solution 1, 2
• Titrate based on hemodynamic response (blood pressure, heart rate, rhythm) rather than fixed schedules 1

Pediatric Protocol

• Dose: 0.6 mL/kg of 10% calcium gluconate over 5–10 minutes, followed by continuous infusion at 0.3 mEq/kg/hour 1, 6
• Alternatively, use 20 mg/kg (0.2 mL/kg) of 10% calcium chloride IV over 5–10 minutes if central access is available 6

Evidence Quality

The evidence base for calcium in calcium channel blocker toxicity consists primarily of animal studies showing consistent benefit, but human case reports and case series demonstrate variable efficacy with low certainty of evidence 5, 1. Despite this limitation, the 2019 ACC/AHA/HRS guidelines give calcium a Class IIa recommendation (reasonable to use) based on improvements in heart rate and blood pressure coupled with low risk of adverse effects 5.

Critical Administration Guidelines

Route and Access

• Preferred access: Central venous catheter to avoid extravasation injury 1, 2, 3
• Peripheral access: If only peripheral access is available, calcium gluconate is strongly preferred over calcium chloride because calcium chloride causes severe tissue necrosis if extravasation occurs 1, 2, 6
• Use a secure IV line to prevent calcinosis cutis and tissue necrosis 2, 3

Dilution and Preparation

• For bolus administration: Dilute to a concentration of 10–50 mg/mL in 5% dextrose or normal saline 3
• For continuous infusion: Dilute to a concentration of 5.8–10 mg/mL 3
• Use the diluted solution immediately after preparation 3
• Inspect visually prior to administration; solution should appear clear and colorless to slightly yellow 3

Cardiac Monitoring Requirements

• Continuous ECG monitoring is mandatory during all calcium administration to detect bradycardia or arrhythmias 1, 2, 3
• Stop infusion immediately if heart rate decreases by ≥10 beats/minute or symptomatic bradycardia occurs 1, 2
• Even "slow push" administration (over 5–10 minutes for emergency situations) carries arrhythmia risk and requires careful rate control 1

Serum Calcium Monitoring

• Measure serum calcium every 4–6 hours during intermittent infusions 3
• Measure serum calcium every 1–4 hours during continuous infusion 3
• For post-parathyroidectomy patients, measure ionized calcium every 4–6 hours for the first 48–72 hours, then twice daily until stable 1

Critical Drug Incompatibilities and Contraindications

Absolute Contraindications

• Hypercalcemia 3
• Neonates ≤28 days receiving ceftriaxone due to risk of fatal ceftriaxone-calcium precipitates 3

Drug Incompatibilities

• Never mix with sodium bicarbonate in the same IV line—precipitation will occur 1, 2, 3
• Never mix with phosphate-containing fluids—calcium-phosphate precipitation can occur 1, 3
• Do not mix with vasoactive amines (epinephrine, dopamine) 1, 2, 3
• Do not mix with minocycline—calcium complexes minocycline rendering it inactive 3
• Do not mix with ceftriaxone—concurrent use can lead to formation of ceftriaxone-calcium precipitates 3

Digoxin Interaction

• Avoid calcium administration in patients receiving cardiac glycosides whenever possible; hypercalcemia increases the risk of digoxin toxicity and life-threatening arrhythmias 1, 3
• If calcium is absolutely necessary in digoxin-treated patients, administer slowly in small aliquots with close ECG monitoring 1

Special Clinical Situations and Precautions

Elevated Phosphate Levels

• Exercise extreme caution when serum phosphate is elevated; additional calcium increases the risk of calcium-phosphate precipitation in tissues, causing obstructive uropathy 1
• Consider renal consultation before aggressive calcium replacement in hyperphosphatemia 1

Renal Impairment

• Initiate at the lowest dose of the recommended range for all age groups 3
• Monitor serum calcium levels every 4 hours 3

Asymptomatic Hypocalcemia

• Do not treat asymptomatic hypocalcemia, even in the setting of tumor lysis syndrome—no calcium replacement is indicated and may be harmful 1, 2

Calcium Chloride vs. Calcium Gluconate

• Calcium chloride provides approximately three times more elemental calcium per unit volume than calcium gluconate (10 mL of 10% calcium chloride contains 5 mmol calcium vs. 10 mL of 10% calcium gluconate contains 2.2 mmol calcium) 1, 6, 4
• Calcium chloride is preferred for critically ill patients requiring rapid correction because it raises ionized calcium more rapidly 6
• Calcium chloride should only be administered via central line due to its highly irritant properties 6, 4

Post-Parathyroidectomy Management

• For ionized calcium <0.9 mmol/L, initiate calcium gluconate infusion at 1–2 mg elemental calcium per kg per hour 1
• Adjust infusion rate to maintain ionized calcium in the normal range (1.15–1.36 mmol/L) 1
• Gradually reduce infusion when calcium normalizes and remains stable, then transition to oral calcium carbonate and calcitriol 1

Common Pitfalls to Avoid

• Do not use fixed dosing schedules—titrate repeat doses based on clinical response (symptoms, ECG changes, hemodynamics) rather than predetermined intervals 1
• Do not administer rapidly—rapid infusion can cause hypotension, bradycardia, and cardiac arrhythmias 1, 3
• Do not forget that calcium's effect in hyperkalemia is temporary—it only protects against arrhythmias for 30–60 minutes and does not lower potassium levels; concurrent potassium-lowering therapies are essential 5, 2
• Do not overlook the need for continuous ECG monitoring—arrhythmias can occur even with slow administration, particularly in patients on digoxin 1, 3
• Do not use peripheral access for calcium chloride—severe tissue necrosis will occur with extravasation 1, 6